[Ophthalmologic findings in graft versus host disease (GvHD)]
- PMID: 8397319
- DOI: 10.1055/s-2008-1045634
[Ophthalmologic findings in graft versus host disease (GvHD)]
Abstract
Background: Since the era of bone marrow transplantation, the picture of acute and/or chronic transplant reaction of the host cells against grafted bone marrow has become more frequent. The so-called adaptive immune therapy bases on the fact that patients who present with a low grade of GvHD less often suffer from a relapse of the malignant leukaemic disease. Therefore, new therapeutic regimen are now performed which keep the patient on a low level of GvHD to prevent a recurrence of leukaemia. Here a close cooperation of oncologists and ophthalmologists becomes more and more important to estimate the stage of GvHD.
Patients: Demonstrating two case reports, we report on the ophthalmological symptoms of acute and chronic GvHD. Both patients presented with acute ocular GvHD as well as with signs of chronic ocular GvHD. Concerning the ophthalmological symptoms, in acute or chronic GvHD the conjunctival involvement is most important. There is a lymphocytic infiltration of the conjunctiva and of the lacrimal glands which leads to an extreme sicca-syndrome. The acute GvHD of the conjunctiva can be classified into 4 stages: injection/exudation and chemosis/formation of pseudomembranes/defects of the corneal epithelium. These stages correlate directly to the prognosis of the survival time of the patient. A pathognomonic sign for the chronic GvHD of the conjunctiva are the fibrous-scarry Arlt-lines of the tarsal conjunctiva.
Conclusions: All patients who underwent a bone marrow transplantation for leukaemia need to be followed up closely to estimate the level of GvHD they are in. This applies especially to those patients who are treated according to the regimen of adaptive immune therapy. A close cooperation of oncologists and ophthalmologists during adaptive immune therapy is mandatory, as the ophthalmologist can provide important information to help to grade the level of GvHD, judging by the morphological picture at the slit lamp.
Similar articles
-
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.Bone Marrow Transplant. 1990 Jun;5(6):413-8. Bone Marrow Transplant. 1990. PMID: 2164434
-
Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.Bone Marrow Transplant. 1990 Jul;6 Suppl 1:94-7. Bone Marrow Transplant. 1990. PMID: 2390646
-
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.Bone Marrow Transplant. 1997 Dec;20(12):1057-62. doi: 10.1038/sj.bmt.1701031. Bone Marrow Transplant. 1997. PMID: 9466278
-
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.Dan Med Bull. 2002 May;49(2):89-108. Dan Med Bull. 2002. PMID: 12064093 Review.
-
Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.Annu Rev Med. 2003;54:29-52. doi: 10.1146/annurev.med.54.101601.152339. Epub 2001 Dec 3. Annu Rev Med. 2003. PMID: 12359826 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical